SMAD2 and hepatocellular carcinoma: TGF-β stimulates SMAD Family Member 2/3 (SMAD2/3) and interacts with interleukin (IL)-21 to enhance the maturation of CD4+ T cells into Th17 cells, which produce IL-17 and contribute to the development of HCC (35).